KERN

Akerna Corp. KERN

Trading inactive

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode KERN ATLN BLPH HSTO SEEL VIRI MSPR HUGE CMAX TCBP
6M -94.97 % -21.93 % -76.47 % -93.33 % -97.25 % -98.50 % -94.10 % -99.82 % 19 059.09 % -99.38 %
YTD -95.93 % -49.66 % 0.00 % -93.55 % -99.79 % -98.94 % -94.62 % -99.85 % 1 586.00 % -94.85 %
1Y -98.22 % -46.13 % -81.27 % -93.73 % -99.82 % -99.11 % -94.36 % -99.90 % -78.49 % -99.80 %
3Y -99.99 % -87.44 % -99.57 % -99.71 % -99.99 % -99.89 % -94.36 % -99.92 % -99.76 % -100.00 %
5Y -99.99 % -98.35 % -99.79 % -99.97 % -99.99 % -99.96 % -94.36 % -99.99 % -99.86 % -100.00 %
10Y -99.99 % -98.35 % -99.99 % -100.00 % -100.00 % -99.96 % -94.36 % -99.99 % -99.86 % -100.00 %
Depuis le début -99.99 % -98.35 % -99.99 % -100.00 % -100.00 % -99.96 % -94.36 % -99.99 % -99.86 % -100.00 %

Dividende

Bellerophon Therapeutics, Inc.